Inflammation is involved in the earliest stages of atherosclerosis

AI Summary

A study led by Spain's Centro Nacional de Investigaciones Cardiovasculares Carlos III finds that systemic inflammation is involved in atherosclerosis from its earliest stages. The research suggests inflammation contributes to disease development independently of traditional risk factors such as high cholesterol and hypertension.

Inflammation plays an important role in the development of atherosclerosis from its earliest stages, long before the onset of symptoms or cardiovascular events such as heart attack or stroke. This is the main conclusion of a study led by a team at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and published in the European Heart Journal. The research shows that systemic inflammation contributes to disease development independently of traditional cardiovascular risk factors such as elevated cholesterol and hypertension.